Accueil   Diary - News   All news Signia Therapeutics, Cynbiose and the VirPath academic laboratory announce the launch of the METABIOSE project

Signia Therapeutics, Cynbiose and the VirPath academic laboratory announce the launch of the METABIOSE project

 

 

This R&D project aims to advance the development of innovative therapeutic treatments in the field of respiratory infections.

 

 

Signia Therapeutics, Cynbiose and the VirPath academic laboratory announce the launch of the METABIOSE project, winner of the 2019 R&D Booster award, supported by the Regional Innovation Fund of the Auvergne Rhône Alpes region.

 

 

The METABIOSE project aims to advance the development of new therapeutic treatments in the field of respiratory infections as part of a unique collaboration between a biotech with a disruptive technology, an innovative preclinical CRO and an academic laboratory of excellence.

 

 

 

Read the press release